medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 615

<< Back Next >>

Rev Med Cos Cen 2015; 72 (615)

Síndrome de presunta histoplasmosis ocular

Ramírez AAK

Language: Spanish
References: 11
Page: 423-426
PDF size: 202.13 Kb.


ABSTRACT

Presumed ocular histoplasmosis (POHS) is an inflammatory syndrome that has been associated with systemic infection by Histoplasma capsulatum. POHS is considered “presumed” ocular histoplasmosis because the causal relationship between the fungus and the eye disease has not been definitively proven. The most accepted theory of the pathogenesis of the disease suggests a hematogenous dissemination of Histoplasma capsulatum during systemic infection. The symptoms associated with ocular histoplasmosis are wide ranging and are dependent on the pathology present. Classically, the ocular manifestations of POHS include discrete atrophic choroidal scars, peripapillary atrophy and choroidal neovascularization.


REFERENCES

  1. Ciullia T, Piper H, Xiao M, Wheat J. Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies. Curr Opin Ophthalmol. 2001, 12:442– 449.

  2. Ehlers J, Hawkins B, Schachat A. Ocular histoplasmosis. En: Ryan A, Sadda A, Hilton D, Schachat A, Wilkinson C, Widemann P. Retina. 5ed. United States, Elsevier, 2013. 1274-1284.

  3. Fowler B, Shen C, Mastellone J, Chaum E. Case report: Acute systemic histoplasmosis associated with chorioretinitis in an inmunocompetent adolescent. Digit J Ophthalmol. 2011; 17(3):31-35.

  4. Hernandez J. Muñoz-Cadavid C. Hernandez D, Montoya C. Gonzalez A. Detection of Histoplasma capsulatum DNA in pheripheral blood from a patient with ocular histoplasmosis síndrome. Med Mycol. 2012; 50: 202- 206.

  5. Humeyra D, Kaplan H, Duffy B, Phelan D, Mohanakumar T, Jaramillo A. Association of the HLA-DR15/HLADQ6 Haplotype With Development of choroidal Neovascular Lesions in Presumed Ocular Histoplasmosis Syndrome. Hum Immunol. 2003; 64, 960–964.

  6. Oliver A, Ciullia T, Cormer G. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment. Curr Opin Ophthalmol. 2005; 16:160-165.

  7. Prasad A, Van Gelder R. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol. 2005; 16:364-368.

  8. Spaide R. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol. 1999; 10: 177–181.

  9. Suttorp-Schulten. Commentary on histoplasmosis: the etiology of the presumed ocular histoplasmosis syndrome. Ocul Immunol Inflamm. 1997; 5: 71-72.

  10. Thuruthumaly C, Chin-Yee D, Kumar-Rao P. Presumed ocular histoplasmosis. Curr Opin Ophthalmol. 2014, 25: 01-05.

  11. Wheat J, Freifeld A, Kleiman M, Baddley J, McKinsey D, Loyd J, Kauffman C. Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2007; 45:807–825.




2020     |     www.medigraphic.com